How Ph.D. was paid
$11.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| R. Scott Struthers, Ph.D.President and Chief Executive Officer | $718,500 | $3,280,540 | $7,160,564 | $462,355 | $7,000 | $11,628,959 |
| Tobin SchilkeChief Financial Officer | $452,250 | $1,755,000 | $1,670,920 | $206,056 | $273,667 | $4,357,893 |
| Dana Pizzuti, M.D.Chief Medical and Development Officer | $573,333 | $1,584,980 | $1,487,018 | $258,000 | $7,000 | $3,910,331 |
| Stephen F. Betz, Ph.D.Chief Scientific Officer | $520,000 | $1,584,980 | $1,487,018 | $228,150 | $7,000 | $3,827,148 |
| Jeff KnightChief Operating Officer | $511,667 | $1,584,980 | $1,487,018 | $236,006 | $7,000 | $3,826,671 |
| Marc WilsonFormer Chief Financial Officer | $119,788 | $514,620 | $2,556,937 | — | $64,047 | $3,255,392 |
What changed and why
- $11.6MR. Scott Struthers received a total compensation of $11,628,959 in 2025, compared to $10,533,579 in 2024.
- 150%The company amended its annual incentive program in 2025 to cap payouts at 150% of target.
- Named executive officers received both stock options and restricted stock units vesting over four years.
- 96.9%Approximately 96.9% of votes cast supported the say-on-pay proposal at the 2025 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.